Overview

Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Revlimid will help maintain patients with acute myeloid leukemia in remission.
Phase:
Phase 2
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
Celgene Corporation
Treatments:
Lenalidomide